Q-omics provides the consensus-scored LINC01766 profile across patient tissues and cancer cell-line models. LINC01766 expression is associated with patient survival in 13 of 34 cancer types, with the highest sampling consensus in BLCA. Additionally, LINC01766 RNA expression shows 6,650 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight BLCA, and STAD as cancer lineages where LINC01766 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for LINC01766 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes LINC01766 survival associations across molecular data types. LINC01766 RNA expression shows survival associations in the most cancer types (13). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

LINC01766 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	13	BLCA (69)	view →

This table ranks reproducible LINC01766 RNA expression–survival associations across cancer types. High LINC01766 expression shows unfavorable associations in BLCA, CESC, MESO, THYM, THCA and LUAD. The BLCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .003). Together, the overview and detailed table identify BLCA as the clearest survival context for LINC01766 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	IV	0.261	0.631	.003	69	view →
CESC	DFS	Tertile	II,III,IV	0.547	0.801	.018	54	view →
MESO	OS	Tertile	All	0.052	0.528	.016	54	view →
THYM	OS	Tertile	All	0.186	0.880	<.001	36	view →
THCA	OS	Tertile	III,IV	0.503	0.945	<.001	30	view →
LUAD	OS	Tertile	III,IV	0.083	0.680	<.001	18	view →

Pink = unfavorable, green = favorable. all 13 lineages →

LINC01766-BLCA (OS)

Kaplan–Meier survival curve for LINC01766 RNA expression in BLCA: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with LINC01766 in patient tissues and cancer cell lines. In patient samples, LINC01766 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	6,650	STAD (5787)	view →
RNA	5,977	HNSC (990)	view →